Low incidence of retinitis pigmentosa among heterozygous carriers of a specific rhodopsin splice site mutation
- PMID: 7558711
Low incidence of retinitis pigmentosa among heterozygous carriers of a specific rhodopsin splice site mutation
Abstract
Purpose: To determine whether a rhodopsin splice donor site mutation at the 5' end of intron 4 is a cause of autosomal dominant retinitis pigmentosa.
Methods: Heterozygous carriers of the same rhodopsin splice site mutation in two pedigrees were identified using single-strand conformation polymorphism analysis. Twelve heterozygous carriers were evaluated by ophthalmoscopy. Goldmann kinetic visual fields, dark adaptation thresholds, and full-field electroretinograms including rod intensity-response functions. Clinical findings from the heterozygous carriers of the splice site mutation were compared with those from heterozygous carriers from a separate family with a known recessive rhodopsin null mutation, Glu249X.
Results: Analysis of DNA from 48 members of two pedigrees revealed 25 heterozygous carriers of the splice site mutation, ranging in age from 14 to 82 years. There were no homozygotes with the rhodopsin splice site mutation. Of the 25 heterozygous carriers, 24 were asymptomatic. Eleven asymptomatic heterozygotes were examined, including four older than 65 years of age. They were found to have normal fundi, full visual fields, and slightly elevated final rod dark adaptation thresholds. Their rod electroretinographic b-wave amplitudes were slightly diminished over the full range of blue light intensities. Rod a-wave implicit times were slightly but significantly prolonged in response to the brightest blue flash of light. These subtle abnormalities in rod function were similar to those found in asymptomatic heterozygous carriers of the recessive Glu249X mutation. Only one of the 25 heterozygous carriers of the splice site mutation had symptoms and signs of retinitis pigmentosa.
Conclusions: Because 96% of these heterozygous carriers do not have retinitis pigmentosa, it is unlikely that this mutation in intron 4 is a dominant allele. The subtle abnormalities of rod function found in asymptomatic carriers are similar to those found in heterozygous carriers of a recessive rhodopsin allele. The one heterozygous carrier with retinitis pigmentosa probably has a second mutation in the rhodopsin gene or has a defect or defects in another gene that causes his disease.
Similar articles
-
Phenotypes of stop codon and splice site rhodopsin mutations causing retinitis pigmentosa.Invest Ophthalmol Vis Sci. 1994 Apr;35(5):2521-34. Invest Ophthalmol Vis Sci. 1994. PMID: 8163341
-
A null mutation in the rhodopsin gene causes rod photoreceptor dysfunction and autosomal recessive retinitis pigmentosa.Nat Genet. 1992 Jun;1(3):209-13. doi: 10.1038/ng0692-209. Nat Genet. 1992. PMID: 1303237
-
Clinical features and mutations in patients with dominant retinitis pigmentosa-1 (RP1).Invest Ophthalmol Vis Sci. 2001 Sep;42(10):2217-24. Invest Ophthalmol Vis Sci. 2001. PMID: 11527933
-
The relationship between visual field size and electroretinogram amplitude in retinitis pigmentosa.Invest Ophthalmol Vis Sci. 1996 Jul;37(8):1693-8. Invest Ophthalmol Vis Sci. 1996. PMID: 8675413 Review.
-
Ocular findings in a form of retinitis pigmentosa with a rhodopsin gene defect.Trans Am Ophthalmol Soc. 1990;88:355-88. Trans Am Ophthalmol Soc. 1990. PMID: 2095030 Free PMC article. Review.
Cited by
-
The homeobox gene CHX10/VSX2 regulates RdCVF promoter activity in the inner retina.Hum Mol Genet. 2010 Jan 15;19(2):250-61. doi: 10.1093/hmg/ddp484. Epub 2009 Oct 20. Hum Mol Genet. 2010. PMID: 19843539 Free PMC article.
-
Autosomal recessive retinitis pigmentosa with homozygous rhodopsin mutation E150K and non-coding cis-regulatory variants in CRX-binding regions of SAMD7.Sci Rep. 2016 Feb 18;6:21307. doi: 10.1038/srep21307. Sci Rep. 2016. PMID: 26887858 Free PMC article.
-
Finding and interpreting genetic variations that are important to ophthalmologists.Trans Am Ophthalmol Soc. 2003;101:437-84. Trans Am Ophthalmol Soc. 2003. PMID: 14971589 Free PMC article. Review.
-
Variables and strategies in development of therapeutic post-transcriptional gene silencing agents.J Ophthalmol. 2011;2011:531380. doi: 10.1155/2011/531380. Epub 2011 Jun 30. J Ophthalmol. 2011. PMID: 21785698 Free PMC article.
-
The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy.Prog Retin Eye Res. 2018 Jan;62:1-23. doi: 10.1016/j.preteyeres.2017.10.002. Epub 2017 Oct 16. Prog Retin Eye Res. 2018. PMID: 29042326 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources